Back to search

Article

Two cases of proteasome inhibitors related thrombotic microangiopathies and literature review

2025-09-04

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Multiple myeloma (MM) is a prevalent hematological malignancy, with proteasome inhibitors (PIs) playing a crucial role in its therapeutic management. Although PIs are generally well-tolerated and associated with relatively mild side effects, recent evidence has increasingly drawn attention to proteasome inhibitor-related thrombotic microangiopathy (PI-related...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e788c4a-6879-54fd-a1bf-79b9042155a3
DOI
10.21203/rs.3.rs-7388047/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Two cases of proteasome inhibitors related thrombotic microangiopathies and literature reviewDOI 10.21203/rs.3.rs-7388047/v1
Select a neighboring publication to make it the new centre.